# MAYO CLINIC ARIZONA: A Phase II Clinical Trial to Test the Efficacy of Rimegepant for Endometriosis-Associated Pain

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | MAYO CLINIC ARIZONA |
| Location | SCOTTSDALE, AZ |
| Project | A Phase II Clinical Trial to Test the Efficacy of Rimegepant for Endometriosis-Associated Pain |
| Project number | 1R01HD121791-01 |
| Mechanism | R01 |
| Institute | Eunice Kennedy Shriver National Institute of Child Health and Human Development |
| Award | $2,505,282 |
| Awarded | 2026-09-14 |
| Project period | 2026-09-11 to 2029-08-31 |
| UEI | ULMJJBL7ZXX3 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11346506). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.